ConductScience.org, home

Paper · 35637317

Phenotypic drug discovery: recent successes, lessons learned and new directions.

Vincent F and 5 others. Nat Rev Drug Discov, 2022. Cited by 238 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Phenotypic drug discovery: recent successes, lessons learned and new directions. Papers, record 35637317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35637317

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phenotypic drug discovery: recent successes, lessons learned and new directions.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
238
iCite
Relative citation ratio, by iCite
17.9
iCite
Revised in PubMed
2023-06-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vincent FFabienhttps://orcid.org/0000-0002-8782-0225
2Nueda AArseniohttps://orcid.org/0000-0001-8373-500X
3Lee JJonathan
4Schenone MMonica
5Prunotto MMarcohttps://orcid.org/0000-0002-0203-0129
6Mercola MMarkhttps://orcid.org/0000-0002-1430-2013

Source PubMed

Topics2

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DiscoveryMajor topic
Humans

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 HL141084NHLBI NIH HHSUnited StatesP01HL141084PubMedNIH RePORTER
R01 HL130840NHLBI NIH HHSUnited StatesR01HL130840PubMedNIH RePORTER
R01 HL138539NHLBI NIH HHSUnited StatesR01HL138539PubMedNIH RePORTER
R01 HL152055NHLBI NIH HHSUnited StatesR01HL152055PubMedNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in35,688,887Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions.https://conductscience.org/library/papers/35688887

Source PubMed

References213

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124,749,835Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect.J Med Chem2014https://conductscience.org/library/papers/24749835PubMed
231,846,577Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-b]pyridazines for the Treatment of Human African Trypanosomiasis.J Med Chem2020https://conductscience.org/library/papers/31846577PubMed
330,840,449Accurate Prediction of Biological Assays with High-Throughput Microscopy Images and Convolutional Networks.J Chem Inf Model2019https://conductscience.org/library/papers/30840449PubMed
427,560,178Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes.Nat Protoc2016https://conductscience.org/library/papers/27560178PubMed
533,257,889'It will change everything': DeepMind's AI makes gigantic leap in solving protein structures.Nature2020https://conductscience.org/library/papers/33257889PubMed
624,429,096A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.Lancet Respir Med2013https://conductscience.org/library/papers/24429096PubMed
710,598,554Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.Semin Oncol1999https://conductscience.org/library/papers/10598554PubMed
832,054,125Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ.Biomolecules2020https://conductscience.org/library/papers/32054125PubMed
929,718,665Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective.J Med Chem2018https://conductscience.org/library/papers/29718665PubMed
1032,294,346A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.N Engl J Med2020https://conductscience.org/library/papers/32294346PubMed

Cited by159

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 238 citations.

PMIDTitleJournalYearIn PapersSource
42,973,959SCOPE-based target and pathway enrichment identifies the histamine H1 receptor as a regulator of exodosis.Front Pharmacol2026https://conductscience.org/library/papers/42973959PubMed
42,959,9826‑Chloropyridinyl Benzoate Fragments as Selective Anti-Melanoma Scaffolds Triggering ROS-Mediated Mitochondrial Apoptosis.ACS Omega2026https://conductscience.org/library/papers/42959982PubMed
42,943,318Antiviral Agents, 2024.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943318PubMed
42,928,229In vitro bioactivity profile-driven discovery of drug synergies in hepatocellular carcinoma.J Transl Med2026https://conductscience.org/library/papers/42928229PubMed
42,907,469High-content morphological profiling by Cell Painting in 3D spheroids.Nat Commun2026https://conductscience.org/library/papers/42907469PubMed
42,901,891Learning chemical-induced gene expression perturbations with WAVE.Nat Commun2026https://conductscience.org/library/papers/42901891PubMed
42,890,046DEG2MOL: Conditional Latent Flow Matching for Transcriptome-Guided de novo Drug Design.ACS Omega2026https://conductscience.org/library/papers/42890046PubMed
42,870,030A selective NVL inhibitor suppresses tumor growth by targeting ribosome biogenesis.Nat Chem Biol2026https://conductscience.org/library/papers/42870030PubMed
42,856,504High-Throughput Screening Identifies Novel Antileishmanial Scaffolds and Reveals Cross-Species Activity of Structurally Diverse Compounds.Res Sq2026https://conductscience.org/library/papers/42856504PubMed
42,819,352SpotOn: A Tool to Enhance Echo Acoustic Standard Deposition for Quantitative Mass Spectrometry Imaging.Chem Biomed Imaging2026https://conductscience.org/library/papers/42819352PubMed

1 to 10 of 159

See all 159 cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35637317

GET https://conductscience.org/api/papers/v1/35637317/references?page=2